Madhukar Rai Selected Research

Madhukar Rai Research Topics

Disease

27	Visceral Leishmaniasis (Kala Azar) 11/2021 - 12/2002
7	Leishmaniasis 01/2015 - 12/2002
5	Systemic Lupus Erythematosus (Libman-Sacks Disease) 02/2016 - 07/2013
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 03/2020 - 12/2017
2	Insulin Resistance 03/2020 - 12/2017
2	Neoplasms (Cancer) 01/2020 - 04/2013
2	Acquired Immunodeficiency Syndrome (AIDS) 11/2015 - 01/2014
2	Infections 01/2013 - 01/2013
1	Duodenal Ulcer (Curling's Ulcer) 06/2020
1	Gastritis 06/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 03/2020
1	Genetic Predisposition to Disease (Genetic Predisposition) 03/2020
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2020
1	Blast Crisis (Blast Phase) 01/2020
1	Acute-Phase Reaction 01/2020
1	Papillomavirus Infections 12/2018
1	Hypothyroidism 12/2017
1	Obesity 12/2017
1	Autoimmune Diseases (Autoimmune Disease) 02/2016
1	Brain Diseases (Brain Disorder) 10/2013
1	Seizures (Absence Seizure) 10/2013
1	Glomerulonephritis 07/2013
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 04/2013
1	Carcinoid Tumor (Carcinoid) 04/2013
1	Neuroendocrine Carcinoma 04/2013
1	Communicable Diseases (Infectious Diseases) 01/2013
1	Body Weight (Weight, Body) 02/2010
1	Hepatocellular Carcinoma (Hepatoma) 08/2007
1	Thalassemia 06/2005
1	Cutaneous Leishmaniasis 12/2002

Drug/Important Bio-Agent (IBA)

5	AutoantibodiesIBA 02/2016 - 07/2013
5	AntigensIBA 12/2015 - 04/2012
5	miltefosine (Impavido)IBA 01/2015 - 12/2002
5	Amphotericin B (Amphotericin)FDA LinkGeneric 01/2014 - 02/2004
4	Pharmaceutical PreparationsIBA 10/2012 - 12/2002
3	Paromomycin (Paromomycin Sulfate)FDA LinkGeneric 11/2021 - 09/2009
3	LipidsIBA 03/2020 - 02/2004
3	RNA (Ribonucleic Acid)IBA 01/2016 - 05/2014
3	Nuclear Antigens (Extractable Nuclear Antigens)IBA 12/2015 - 07/2013
3	liposomal amphotericin B FDA Link 03/2015 - 12/2002
2	CytokinesIBA 01/2020 - 10/2014
2	MicroRNAs (MicroRNA)IBA 02/2016 - 05/2014
2	Messenger RNA (mRNA)IBA 10/2014 - 07/2013
2	deoxycholate drug combination amphotericin BIBA 08/2008 - 02/2004
2	AntimonyIBA 03/2006 - 12/2002
1	AntralIBA 06/2020
1	Blood Glucose (Blood Sugar)IBA 03/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	Interferon Type IIBA 01/2020
1	InterferonsIBA 01/2019
1	Interleukin-2 (IL2)IBA 01/2019
1	Thyroxine (Levothyroxine)FDA LinkGeneric 12/2017
1	ChemokinesIBA 10/2014
1	Interleukin-12 (IL 12)IBA 10/2014
1	GraphiteIBA 01/2014
1	AminesIBA 01/2014
1	Metronidazole (Metric)FDA LinkGeneric 10/2013
1	N(1)-methyl-2-lysergic acid diethylamide (MIL)IBA 10/2013
1	Biological ProductsIBA 04/2013
1	Proteins (Proteins, Gene)FDA Link 01/2013
1	Biomarkers (Surrogate Marker)IBA 01/2013
1	Kinetoplast DNA (kDNA)IBA 01/2013
1	LigandsIBA 08/2012
1	18S Ribosomal RNAIBA 06/2012
1	Carbon Nanotubes (Carbon Nanotube)IBA 01/2012
1	Interleukin-10 (Interleukin 10)IBA 10/2011
1	InsecticidesIBA 12/2010
1	leishmaninIBA 04/2009
1	PolyestersIBA 12/2007
1	Polyethylene (Polythene)IBA 12/2007
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 08/2007
1	beta-Globins (beta Globin)IBA 06/2005
1	S(8)IBA 06/2005
1	Fluconazole (Zonal)FDA LinkGeneric 12/2002
1	8-aminoquinolineIBA 12/2002

Therapy/Procedure

6	Therapeutics 03/2020 - 12/2002
2	Highly Active Antiretroviral Therapy (HAART) 03/2020 - 01/2014
1	Art Therapy 11/2015
1	Length of Stay 10/2013
1	Duration of Therapy 02/2011